NEW YORK (GenomeWeb News) – OncoMethylome Sciences said Tuesday it has contracted the German company Signature Diagnostics to help it manage the German component of its multi-center clinical trials for a colorectal cancer diagnostic.
 
Under the agreement, OncoMethylome also has acquired a minority interest in Potsdam-based Signature Diagnostics, and it will give the company an up-front payment as well as service fees. Additional financial terms of the agreement were not disclosed.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Parabon NanoLabs is partnering with law enforcement to use genetic genealogy approaches to solve cold cases, Buzzfeed News reports.

A Columbia University-led team used emergency contact information from medical records to create family trees and estimate disease heritability.

NPR says a new report recommends that former research chimpanzees should be moved to retirement sanctuaries unless that move would shorten their lives.

In Science this week: ancient Southeast Asian genomes provide insight on human migration, and more.